Neoplastic diseases in families of breast cancer patients
- PMID: 7815419
- PMCID: PMC1050023
- DOI: 10.1136/jmg.31.8.618
Neoplastic diseases in families of breast cancer patients
Abstract
Objective: To investigate whether the risk of cancer at all sites, and at individual sites other than breast, prostate, ovaries, and endometrium, is increased among relatives of breast cancer patients compared with the general population.
Design: A cohort of family members of breast cancer patients was established. The probands were chosen by year of birth or time of diagnosis. Any influence of knowledge of the cancer experience of the relatives has been avoided. The risk estimates are based on expected numbers computed from age and time specific incidence rates for the Icelandic population.
Setting: Iceland.
Subjects: The population of Iceland.
Main outcome measures: Relative risks by degree of relatedness and age of proband.
Results: The relative risk of cancer at all sites is raised for males and females. This is more than expected based on the known familial risk of breast cancer, prostate, and ovarian cancer. The excess risk of breast, prostate, and ovarian cancer is confirmed, but not that of cancer of the endometrium. The risk of cancer of the pancreas in both sexes and the stomach and kidneys in females is significantly raised. No evidence was found for decreased risk for any cancer type.
Conclusions: The risk of cancer at all sites in relatives of breast cancer patients is increased. In addition to the risk of breast, prostate, and ovarian cancer, the risk of pancreas cancer and cancer of the stomach and kidneys in females is raised, but the last mentioned observations need further confirmation.
Similar articles
-
The effect of a single BRCA2 mutation on cancer in Iceland.J Med Genet. 2002 Jul;39(7):457-62. doi: 10.1136/jmg.39.7.457. J Med Genet. 2002. PMID: 12114473 Free PMC article.
-
Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.BMJ. 1992 Oct 10;305(6858):855-7. doi: 10.1136/bmj.305.6858.855. BMJ. 1992. PMID: 1422397 Free PMC article.
-
Cancer risks in BRCA2 mutation carriers.J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6. doi: 10.1093/jnci/91.15.1310. J Natl Cancer Inst. 1999. PMID: 10433620
-
[Hereditary gastric and pancreatic cancer predisposition syndromes].Gastroenterol Hepatol. 2016 Aug-Sep;39(7):481-93. doi: 10.1016/j.gastrohep.2015.11.009. Epub 2016 Feb 23. Gastroenterol Hepatol. 2016. PMID: 26916701 Review. Spanish.
-
[Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes].Salud Publica Mex. 2011 Sep-Oct;53(5):420-9. Salud Publica Mex. 2011. PMID: 22218796 Review. Spanish.
Cited by
-
Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.Int J Pancreatol. 1994 Oct-Dec;16(2-3):183-310. doi: 10.1007/BF02944330. Int J Pancreatol. 1994. PMID: 7868945 No abstract available.
-
Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary.J Breast Cancer. 2012 Sep;15(3):283-7. doi: 10.4048/jbc.2012.15.3.283. Epub 2012 Sep 28. J Breast Cancer. 2012. PMID: 23091540 Free PMC article.
-
Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.PLoS Med. 2004 Dec;1(3):e65. doi: 10.1371/journal.pmed.0010065. Epub 2004 Dec 28. PLoS Med. 2004. PMID: 15630470 Free PMC article.
-
Pancreatic adenocarcinoma: epidemiology and genetics.J Med Genet. 1996 Nov;33(11):889-98. doi: 10.1136/jmg.33.11.889. J Med Genet. 1996. PMID: 8950667 Free PMC article. Review.
-
High risk factors of pancreatic carcinoma.J Huazhong Univ Sci Technolog Med Sci. 2016 Jun;36(3):295-304. doi: 10.1007/s11596-016-1583-x. Epub 2016 Jul 5. J Huazhong Univ Sci Technolog Med Sci. 2016. PMID: 27376795 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical